Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
17.25
+0.59 (3.54%)
Oct 20, 2025, 4:00 PM EDT - Market closed

Denali Therapeutics Statistics

Total Valuation

DNLI has a market cap or net worth of $2.53 billion. The enterprise value is $1.60 billion.

Market Cap2.53B
Enterprise Value 1.60B

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025, after market close.

Earnings Date Nov 5, 2025
Ex-Dividend Date n/a

Share Statistics

DNLI has 146.42 million shares outstanding. The number of shares has increased by 14.84% in one year.

Current Share Class 146.42M
Shares Outstanding 146.42M
Shares Change (YoY) +14.84%
Shares Change (QoQ) +0.13%
Owned by Insiders (%) 4.79%
Owned by Institutions (%) 94.54%
Float 132.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.45
P/TBV Ratio 2.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.27, with a Debt / Equity ratio of 0.05.

Current Ratio 10.27
Quick Ratio 9.89
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -313.87

Financial Efficiency

Return on equity (ROE) is -39.69% and return on invested capital (ROIC) is -26.56%.

Return on Equity (ROE) -39.69%
Return on Assets (ROA) -24.99%
Return on Invested Capital (ROIC) -26.56%
Return on Capital Employed (ROCE) -49.63%
Revenue Per Employee n/a
Profits Per Employee -$1.14M
Employee Count422
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, DNLI has paid $68,000 in taxes.

Income Tax 68,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.48% in the last 52 weeks. The beta is 1.29, so DNLI's price volatility has been higher than the market average.

Beta (5Y) 1.29
52-Week Price Change -37.48%
50-Day Moving Average 14.82
200-Day Moving Average 15.81
Relative Strength Index (RSI) 68.28
Average Volume (20 Days) 1,895,765

Short Selling Information

The latest short interest is 14.15 million, so 9.66% of the outstanding shares have been sold short.

Short Interest 14.15M
Short Previous Month 13.08M
Short % of Shares Out 9.66%
Short % of Float 10.70%
Short Ratio (days to cover) 5.78

Income Statement

Revenue n/a
Gross Profit -396.06M
Operating Income -533.58M
Pretax Income -478.97M
Net Income -479.03M
EBITDA -529.42M
EBIT -533.58M
Earnings Per Share (EPS) -$2.81
Full Income Statement

Balance Sheet

The company has $898.95 million in cash and $47.97 million in debt, giving a net cash position of $929.44 million or $6.35 per share.

Cash & Cash Equivalents 898.95M
Total Debt 47.97M
Net Cash 929.44M
Net Cash Per Share $6.35
Equity (Book Value) 1.03B
Book Value Per Share 7.05
Working Capital 843.65M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$349.62 million and capital expenditures -$18.33 million, giving a free cash flow of -$367.95 million.

Operating Cash Flow -349.62M
Capital Expenditures -18.33M
Free Cash Flow -367.95M
FCF Per Share -$2.51
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

DNLI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -14.84%
Shareholder Yield -14.84%
Earnings Yield -18.97%
FCF Yield -14.57%
Dividend Details

Analyst Forecast

The average price target for DNLI is $33.50, which is 94.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target $33.50
Price Target Difference 94.20%
Analyst Consensus Strong Buy
Analyst Count 14
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -32.47%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1